These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1195283)

  • 1. Absolute configuration of the major metabolite of 5,5-diphenylhydantoin, 5-(4'-hydroxyphenyl)-5-phenylhydantoin.
    Poupaert JH; Cavalier R; Claesen MH; Dumont PA
    J Med Chem; 1975 Dec; 18(12):1268-71. PubMed ID: 1195283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute configuration of (+)-5-(o-hydroxyphenyl)-5-phenylhydantoin, the major metabolite of 5,5-diphenylhydantoin in the dog.
    Maguire JH; Butler TC; Dudley KH
    J Med Chem; 1978 Dec; 21(12):1294-7. PubMed ID: 722736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute configurations of the dihydrodiol metabolites of 5,5-diphenylhydantoin (phenytoin) from rat, dog, and human urine.
    Maguire JH; Butler TC; Dudley KH
    Drug Metab Dispos; 1980; 8(5):325-31. PubMed ID: 6107230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemical aspects of the metabolism of 5-(4'-fluorophenyl)-5-phenylhydantoin in the rat.
    Poupaert JH; Adline J; Claesen MH; De Laey P; Dumont PA
    J Med Chem; 1979 Sep; 22(9):1140-2. PubMed ID: 490562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
    Huang JD; Hsieh CY
    Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man.
    Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH
    Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiroptical spectroscopic studies for the absolute configuration determination of hexahydrocurcumin and octahydrocurcumin.
    Puente AR; Nagabhushanam K; Ganjihal S; Majeed M; Polavarapu PL
    Chirality; 2022 Dec; 34(12):1515-1525. PubMed ID: 36300855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
    Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
    J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chiral separation of racemic 5-(p-hydroxyphenyl)-5-phenylhydantoin by RP-HPLC using eluents containing beta-cyclodextrin].
    Yao T; Zeng S; Ding H
    Se Pu; 1997 Jul; 15(4):316-8. PubMed ID: 15739464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic-gingival hyperplasia: in vivo and in vitro study.
    Ieiri I; Goto W; Hirata K; Toshitani A; Imayama S; Ohyama Y; Yamada H; Ohtsubo K; Higuchi S
    Eur J Clin Pharmacol; 1995; 49(1-2):51-6. PubMed ID: 8751021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute configuration of an axially chiral sulfonate determined from its optical rotatory dispersion, electronic circular dichroism, and vibrational circular dichroism spectra.
    Covington CL; Raghavan V; Smuts JP; Armstrong DW; Polavarapu PL
    Chirality; 2017 Nov; 29(11):670-676. PubMed ID: 28833487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemical aspects of the metabolism of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
    Maguire JH; Kraus BL; Butler TC; Dudley KH
    Drug Metab Dispos; 1981; 9(5):393-401. PubMed ID: 6117436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute configurations of phytotoxins seiricardine A and inuloxin A obtained by chiroptical studies.
    Santoro E; Mazzeo G; Petrovic AG; Cimmino A; Koshoubu J; Evidente A; Berova N; Superchi S
    Phytochemistry; 2015 Aug; 116():359-366. PubMed ID: 25817835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
    Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH
    Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent density functional response theory for electronic chiroptical properties of chiral molecules.
    Autschbach J; Nitsch-Velasquez L; Rudolph M
    Top Curr Chem; 2011; 298():1-98. PubMed ID: 21321799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereochemistry of the tadalafil diastereoisomers: a critical assessment of vibrational circular dichroism, electronic circular dichroism, and optical rotatory dispersion.
    Qiu S; De Gussem E; Tehrani KA; Sergeyev S; Bultinck P; Herrebout W
    J Med Chem; 2013 Nov; 56(21):8903-14. PubMed ID: 24116968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes.
    Nakajima M; Sakata N; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2002 Nov; 30(11):1250-6. PubMed ID: 12386132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria.
    Takahashi A; Onodera K; Shinoda H; Mayanagi H
    Jpn J Pharmacol; 2000 Jan; 82(1):82-4. PubMed ID: 10874595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute configurations of phytotoxic inuloxins B and C based on experimental and computational analysis of chiroptical properties.
    Evidente M; Santoro E; Petrovic AG; Cimmino A; Koshoubu J; Evidente A; Berova N; Superchi S
    Phytochemistry; 2016 Oct; 130():328-34. PubMed ID: 27498046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical separation of racemic 5-(p-hydroxyphenyl)-5-phenylhydantoin by reversed phase high-performance liquid chromatography using eluents containing beta-cyclodextrin.
    Eto S; Noda H; Minemoto M; Noda A; Mizukami Y
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2742-4. PubMed ID: 1806294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.